| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/22/2004 | WO2002059143A3 Therapeutic peptides for demyelinating conditions |
| 01/22/2004 | US20040016029 Growing a transgenic plant or plant seed transformed with a DNA molecule which encodes for a hypersensitive response elicitor protein or polypeptide |
| 01/22/2004 | US20040016027 Novel rice gene controlling tolerance to salt stress |
| 01/22/2004 | US20040016025 Rice promoters for regulation of plant expression |
| 01/22/2004 | US20040016023 Modification of plant cell wall component and method of regulating development differentiation |
| 01/22/2004 | US20040016022 Methods of use of LEC1 polynucleotides and polypeptides |
| 01/22/2004 | US20040016021 Recombinant viral expression constructs of human alpha galactosidase nucleotide sequences |
| 01/22/2004 | US20040016020 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/22/2004 | US20040016019 Chimeric genes that express in cotton and encode insecticides and fungicides having substantially the insect toxicity and fungal toxicity of barley, nettle, and hevein lectins |
| 01/22/2004 | US20040016018 Plant retroelements and methods related thereto |
| 01/22/2004 | US20040016011 Mouse model for inducing hepatocellular carcinoma by targeted integration of hepatitis B virus genes |
| 01/22/2004 | US20040016009 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery, a method for such delivery, and a non-human mammal susceptible to such delivery |
| 01/22/2004 | US20040016008 Rodent whose genome comprises a mutant amyloid precursor protein transgene and an acetylcholinesterase transgene; use in identifying agents that affect the progression of Alzheimer's disease |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040016004 Novel gene (designated 238P1B2), its encoded protein, and variants thereof exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides diagnostic, prophylactic, therapeutic target for cancer |
| 01/22/2004 | US20040014955 Identification of essential genes of cryptococcus neoformans and methods of use |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014948 Single-chain antagonist polypeptides |
| 01/22/2004 | US20040014947 Comprises learning enhancement polypeptide for diagnosis, treatment and prevention of nervous system and neural degenerative diseases |
| 01/22/2004 | US20040014945 Transporters and ion channels |
| 01/22/2004 | US20040014709 Genetic engineered adenoviral vector coding interferon gene; therapy against bladder cancer |
| 01/22/2004 | US20040014705 Supplying polypeptides; coupling with controller; therapy for autoimmune disease |
| 01/22/2004 | US20040014697 Melanoma antigenic peptides |
| 01/22/2004 | US20040014670 Inhibitors of angiotensin converting enzyme |
| 01/22/2004 | US20040014669 Polypeptides; antiproliferative agents |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014667 Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF); VEGF minitraps useful for treating VEGF-associated conditions and diseases, designed for local administration to specific organs, tissues |
| 01/22/2004 | US20040014665 Genetic engineering; wound healing agents; antidiabetic agents; stimulant gene expression |
| 01/22/2004 | US20040014663 Botulinum toxin treatment for cervical dystonia |
| 01/22/2004 | US20040014661 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 01/22/2004 | US20040014660 Insulin-associated peptides with effects on cerebral health |
| 01/22/2004 | US20040014658 Antitumor agents; wound healing agents; muscular disorders |
| 01/22/2004 | US20040014653 Oral diseases; skin disorders; aging resistance |
| 01/22/2004 | US20040014646 Antibiotics AW998A, AW998B, AW998C and AW998D |
| 01/22/2004 | US20040014644 Prevent gene expression; genetic engineering |
| 01/22/2004 | US20040014643 Method of structure-based drug design to create or improve modular of IL-1 activity which mind to the interleukin-1 type 1 receptor |
| 01/22/2004 | US20040014641 Mammalion haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof |
| 01/22/2004 | US20040014639 Adjust gene expression of adrenergic receptor; synergistic mixture with andrenergic antagonist; control metabolism of lipids, carbohydrates |
| 01/22/2004 | US20040014638 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014242 An insoluble carrier having primary amino groups can be used as the carrier for absorptive immobilizations of a protein containing cysteine group, via ionic interection, then cyanating sulfhydryl group of cysteine with a cyanating agent |
| 01/22/2004 | US20040014218 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 01/22/2004 | US20040014215 Preparing cocurrent plant cultures and isolating cell cycle regulated genes or proteins |
| 01/22/2004 | US20040014207 Dendritic cell potentiation |
| 01/22/2004 | US20040014192 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014186 Preparing thin film composed of silicon and duplicated amino acid sequences; biomineralization; electronics and photonics |
| 01/22/2004 | US20040014180 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014177 Using leukemia cells as bioreactor for production of heterologous protein; gene therapy |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014173 Comprises proteins for diagnosis, prevention and/or treatment of cancer, inflammation, defective wound healing, skin, vision and blood disorders |
| 01/22/2004 | US20040014172 Comprises retroviral polypeptide for generating genetic vaccine for preventing viral infections; viricides; gene expression inhibition |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014169 Novel G protein-coupled receptors |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014158 Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 01/22/2004 | US20040014155 Composition comprising Phleum pratense pollen (PHl P11) proteins for diagnosis and treatment of atopic disease; immunotherapy; immunoassay |
| 01/22/2004 | US20040014153 Using atomic coordinates of bactericidal/permeability-increasing (BPI) protein to design modulators of bacterial infection; drug screening; enzyme inhibitors |
| 01/22/2004 | US20040014151 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 01/22/2004 | US20040014150 Pth analogs for renal osteodystrophy and related uses |
| 01/22/2004 | US20040014149 Relates to compounds that modulate processes associated with isotype switching of B cells and IgE production; treatment of diseases characterized by production or accumulation of IgE, including anaphylactic hypersensitivity, allergic reactions |
| 01/22/2004 | US20040014148 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 01/22/2004 | US20040014143 Classification, separation and detection of neuropeptides; diagnosis and treatment of nervous system disorders |
| 01/22/2004 | US20040014141 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |
| 01/22/2004 | US20040014136 Crystal structure of complement inhibitor (sCR1) for preventing hemolysis, necrosis and tissue destruction |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014126 Comprises peptide with pyruvate dehydrogenase activity for monitoring enzyme modulators; high-throughput assay; drug screening; enzyme inhibitors; tumor diagnosis; antitumor agents |
| 01/22/2004 | US20040014125 Tbx3 gene and methods of using it |
| 01/22/2004 | US20040014123 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 01/22/2004 | US20040014120 Novel proteins and nucleic acids encoding the same |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014103 Using a construct to generate hematopoietic cells harvested in differentiation upon exposure to the appropriate hormone, removing the hormone makes cells have normal synchronous differentiation providing a system for study of the process |
| 01/22/2004 | US20040014083 Detection of heteroduplex polynucleotides using mutant nucleic acid repair enzymes with attenuated catalytic activity |
| 01/22/2004 | US20040014081 Molecule (MOL) polypeptides, vectors, cells, antibodies, and recombinant |
| 01/22/2004 | US20040014074 Nucleic acid and proteins showing increasing expression dose under salt stress |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014053 Novel proteins and nucleic acids encoding same |
| 01/22/2004 | US20040014052 Process for regulating gene expression |
| 01/22/2004 | US20040014046 Preparing candidate vaccine agents based on a polypeptide comprising an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide that induces an immune response |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040014038 G-protein coupled receptor (GPCR) polypeptides, vectors, host cells, antibodies, and recombinant methods for producing nucleic acids/polypeptides; methods for diagnosis, treatment, and prevention of disorders involving these human proteins |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040014036 Transcriptional activation system, activators, and uses therefor |
| 01/22/2004 | US20040014033 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 01/22/2004 | US20040014032 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
| 01/22/2004 | US20040014026 Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkappaB |
| 01/22/2004 | US20040014025 Using a transfer system which is contacted with the cell to be changed, the transfer system comprises a fusion protein which is transferred into the cell using the VirB/VirD4 transfer system |
| 01/22/2004 | US20040014024 Use of stable cell lines genetically engineered to express a recombinant fibroblast growth factor receptor (FGFR) |
| 01/22/2004 | US20040013719 Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules |
| 01/22/2004 | US20040013692 Use of botulinum toxins for treating various disorders and conditions and associated pain |
| 01/22/2004 | US20040013690 Attenuated Listeria spp. and methods for using the same |
| 01/22/2004 | US20040013687 Complexing Clostridium botulinum; translocation; induction immunology response |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013685 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 01/22/2004 | US20040013684 Immunizing against hiv infection |
| 01/22/2004 | US20040013683 Polypeptide viricides; genetic engineering |